| __timestamp | Ionis Pharmaceuticals, Inc. | Veracyte, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 241751000 | 9804000 |
| Thursday, January 1, 2015 | 322292000 | 12796000 |
| Friday, January 1, 2016 | 344320000 | 15324000 |
| Sunday, January 1, 2017 | 374644000 | 13881000 |
| Monday, January 1, 2018 | 414604000 | 14820000 |
| Tuesday, January 1, 2019 | 466000000 | 14851000 |
| Wednesday, January 1, 2020 | 535000000 | 17204000 |
| Friday, January 1, 2021 | 643000000 | 29843000 |
| Saturday, January 1, 2022 | 833000000 | 40603000 |
| Sunday, January 1, 2023 | 899625000 | 57305000 |
| Monday, January 1, 2024 | 901530000 |
Unleashing the power of data
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, Ionis Pharmaceuticals has consistently outpaced Veracyte in R&D investment. From 2014 to 2023, Ionis increased its R&D expenses by approximately 272%, reaching nearly $900 million in 2023. This strategic focus underscores Ionis's dedication to advancing its pipeline and maintaining a competitive edge.
Conversely, Veracyte's R&D spending, while growing, remains modest in comparison. From 2014 to 2023, Veracyte's R&D expenses rose by about 484%, yet they only reached around $57 million in 2023. This disparity highlights differing strategic priorities, with Ionis heavily investing in innovation, while Veracyte may be focusing on other growth avenues. As the biotech industry evolves, these investment strategies will likely shape the future trajectories of both companies.
R&D Insights: How Johnson & Johnson and Ionis Pharmaceuticals, Inc. Allocate Funds
Vertex Pharmaceuticals Incorporated vs Veracyte, Inc.: Strategic Focus on R&D Spending
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Ionis Pharmaceuticals, Inc.
R&D Spending Showdown: argenx SE vs Veracyte, Inc.
Research and Development Investment: Biogen Inc. vs Ionis Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Ionis Pharmaceuticals, Inc. vs ADMA Biologics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Xenon Pharmaceuticals Inc.
Analyzing R&D Budgets: Ionis Pharmaceuticals, Inc. vs ACADIA Pharmaceuticals Inc.
Research and Development: Comparing Key Metrics for Ionis Pharmaceuticals, Inc. and MannKind Corporation
Comparing Innovation Spending: Ionis Pharmaceuticals, Inc. and Dynavax Technologies Corporation
R&D Spending Showdown: Veracyte, Inc. vs Amphastar Pharmaceuticals, Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Viridian Therapeutics, Inc.